Chief Business Officer of Jounce Therapeutics, Inc. (NASDAQ:JNCE), Cole Hugh M, sells 2,879 shares worth $19,462
According to Jounce Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 06:19 AM, company Chief Business Officer, Cole Hugh M disclosed selling 2,879 shares at a cost of $6.76. At the time of this transaction (Jan 07), this trade was worth $19,462 in total. As of Jan 07, Cole Hugh M now owns 58,529 shares in total worth about $427,846.99.
For the last few recent trades made by Jounce Therapeutics, Inc. (NASDAQ:JNCE) Chief Business Officer, Cole Hugh M, we have the following information:
- SEC Form 4 filing: Jan 08: Sold 3,340 shares at the rate of $7.00 per share. Total worth of this trade was $23,380. Total number of shares owned as of Jan 08 were 55,189
- SEC Form 4 filing: Aug 14: Sold 984 shares at the rate of $4.64 per share. Total worth of this trade was $4,566. Total number of shares owned as of Aug 14 were 62,606
- SEC Form 4 filing: Aug 17: Sold 454 shares at the rate of $4.86 per share. Total worth of this trade was $2,206. Total number of shares owned as of Aug 17 were 62,152
Posted by
George Daniels
on Monday January 11 2021, 9:41 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
